Jon Congleton

Jon Congleton has an estimated net worth of $32.9 Million. This is based on reported shares across multiple companies, which include Nivalis Therapeutics, Inc., Mineralys Therapeutics, Inc., IMMUNIC, INC., and Avalyn Pharma Inc..

2023 was Jon Congleton's most active year for acquiring shares with 6 total transactions. Jon Congleton's most active month to acquire stocks was the month of January. 2025 was Jon Congleton's most active year for disposing of shares, totalling 12 transactions. Jon Congleton's most active month to dispose stocks was the month of October. 2015 saw Jon Congleton paying a total of $40,500.00 for 126,100 shares, this is the most they've acquired in one year. In 2025 Jon Congleton cashed out on 288,718 shares for a total of $10,316,141.78, their largest year based on trade value.